Drug Determination in Therapeutic and Forensic Contexts [electronic resource] /

#A Sample Handling and Usefulness of Isotopes -- #A-1 Separation science applied to analyses on biological samples -- #A-2 Sample handling in forensic toxicology -- #A-3 Stable isotopes in pharmacokinetic studies -- #A-4 Isotope-labelled materials as internal standards -- #NC(A) NOTES and COMMENTS related to the foregoing topics -- #NC(A)-1 Approaches for determining ethylenediamine and its metabolites: use of [14C]- and [D4]-ethylenediamine -- #NC(A)-2 Selective sample preparation techniques for trace analysis -- #NC(A)-3 Simplified approaches to the HPLC determination of drugs in biological samples -- #B Strategies for HPLC (Other Than Detection) and for TLC -- #B-1 Development and application of an HPLC pre-concentration device suitable for large amounts of biological sample -- #B-2 Multi-solvent optimization of HPLC separations -- #B-3 Optimization strategies for chromatographic analysis of multi-component mixtures -- #B-4 Reversed-phase TLC on alkyl-bonded and paraffin-coated silica gel -- #NC(B) NOTES and COMMENTS related to the foregoing topics -- #NC(B)-1 Chemically bonded stationary phases in (HP)TLC -- #NC(B)-2 TLC as a pilot technique for reversed-phase HPLC -- #C HPLC Detection, and Determination of Metal-Complex Drugs -- #C-1 Comparative performance of different HPLC systems with electrochemical detection -- #C-2 Specific element chromatographic detection by plasma spectral emission, as applied to organometallies and gold-containing drugs -- #C-3 HPLC-electrochemical determination of cis-platinum anti-cancer drugs -- #C-4 HPLC analysis of cisplatin analogues in biological fluids -- #C-5 The therapeutic use of gold compounds: analytical aspects -- #C-6 Clinical analysis of divalent platinum complexes with anti-neoplastic activity l6l -- #C-7 Solid phase derivatization reactions in HPLC -- #NC(C) NOTES and COMMENTS related to the foregoing topics l8l -- #NC(C)-1 Post-column reaction detectors for trace analysis in HPLC -- #NC(C)-2 Post-column reaction with ferric chloride for the detection of D-penicillamine -- #NC(C)-3 An evaluation of a two-electrode coulometric detector -- #NC(C)-4 A comparison of the moving belt and direct liquid introduction interfaces for HPLC-MS of ranitidine and its metabolites -- #D Tamoxifen and Other Anti-Cancer Drugs -- #D-1 Determination of the anti-cancer drug amsacrine in biological fluids by HPLC -- #D-2 Over-view of problems in determining tamoxifen levels in biological samples -- #D-3 Analysis of tamoxifen and its metabolites -- #D-4 HPLC methodology for therapeutic monitoring of tamoxifen and two major metabolites in blood and tissues -- #D-5 Analyses for tamoxifen, its metabolites and endogenous oestrogens in blood plasma and tumour tissue -- #NC(D) NOTES and COMMENTS related to the foregoing topics -- #NC(D)-1 Determination of tamoxifen and N-desmethyltamoxifen in plasma by HPLC -- #NC(D)-2 Identification of adriamycin and its metabolites in human and animal tissues and blood -- #NC(D)-3 Antibodies to deoxycytidine triphosphate (dCTP) suitable for its radioimmunoassay -- #NC(D)-4 Combined RIA/HPLC of methotrexate and its metabolites -- #NC(D)-5 Radioimmunoassay of methotrexate -- #E Ligand Methods for Drugs in Forensic and other Contexts -- #E-1 Radioimmunoassay in forensic science -- #E-2 Spin immunoassay for drug determination -- #E-3 Advent and present-day status of ligand methods -- #E-4 Radioreceptor assay of anticholinergic drugs in biological fluids -- #E-5 Receptor binding and HPLC analysis of benzodiazepines in a clinical laboratory -- #NC(E) NOTES and COMMENTS related to the foregoing topics -- #NC(E)-1 Assay of secoverine and active metabolites: comparison of stable isotope dilution with receptor binding assay -- #NC(E)-2 Some trends in ligand methods, including fluoroimmunoassay -- #NC(E)-3 Plasma morphine: comparison of results obtained by HPLC and RIA -- #F Various Analytes in Biological and Forensic Samples -- #F-1 HPLC with electrochemical detection: applications for the neurosciences -- #F-2 Gas chromatography with electron-capture detection for measurement of bioactive amines in biological samples -- #F-3 Analysis of the metabolites of bumetanide in urine by HPLC -- #F-4 Assay of compounds of forensic interest -- #F-5 Detection of solvent abuse by direct mass spectrometry on expired air -- #NC(F) NOTES and COMMENTS related to the foregoing topics -- #NC(F)-1 Explosives and other nitro compounds determined by liquid chromatography with photolysis-electrochemical detection -- #NC(F)-2 Nitroglycerin assay in plasma by thermal energy analyzer -- #NC(F)-3 A comparison of HPLC-thermal energy analysis and GC- electron capture detection for determining isosorbide dinitrate and its mononitrate metabolites in human plasma -- #G Analytical Quality Assurance -- #G-1 The role of external quality assessment schemes in the determination of plasma drug levels -- #G-2 Validation of bioanalytical procedures: an example -- #NC(G) NOTES and COMMENTS related to the foregoing topics -- #NC(G)-1 GLP in a chemical-pharmaceutical company: current status and experiences in analytical and drug disposition department -- #NC(G)-2 Quality control systems for routine drug analysis -- Analyte Index -- General Index -- Corrections to vols. 12 & 13.

Bibliographic Details

Main Authors:	Reid, Eric. editor., Wilson, Ian D. editor., SpringerLink (Online service)
Format:	Texto biblioteca
Language:	eng
Published:	Boston, MA : Springer US, 1984
Subjects:	Chemistry., Chemistry/Food Science, general.,
Online Access:	http://dx.doi.org/10.1007/978-1-4613-2397-6
Tags:	Add Tag No Tags, Be the first to tag this record!